Ubrogepant Reduced Migraine-Related Limitations When Taken During the Prodrome Phase
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Ubrogepant Reduced Migraine-Related Limitations When Taken During the Prodrome Phase
-
Narrated by:
-
By:
About this listen
According to a study published in Neurology, when compared to placebo, this gepant led to significantly greater ability to function normally and a greater reduction in activity limitation when taken during the prodrome phase of an attack.
Molly O’Brien has the details in this Migraine Minute News Update.
Read More: https://bit.ly/3BY2J9d
What listeners say about Ubrogepant Reduced Migraine-Related Limitations When Taken During the Prodrome Phase
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.